Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Population Health Management
|
October 8, 2014
Racial/ethnic and gender differences in severity of diabetes-related complications, health care resource use, and costs in a Medicare population
Leslie Hazel-Fernandez, Yong Li, Damion Nero, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
October 22, 2021
Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations
Morgan Justice Fuoco, Richard A Mularski, Benjamin Wu, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
March 28, 2022
Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population
Sanjay Sethi, Barry J Make, Scott B Robinson, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
April 29, 2021
Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities
Ravi Kalhan, David Slade, Riju Ray, et al.
Epilepsia Open
|
December 10, 2023
Early genetic testing in pediatric epilepsy: Diagnostic and cost implications
Shanna M Swartwood, Ana Morales, Kathryn E Hatchell, et al.
Health and Quality of Life Outcomes
|
June 23, 2017
Healthcare utilization and costs for patients initiating Dabigatran or Warfarin
Shannon L Reynolds, Sameer R Ghate, Richard Sheer, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 19, 2015
Development and Validation of a Predictive Model to Identify Individuals Likely to Have Undiagnosed Chronic Obstructive Pulmonary Disease Using an Administrative Claims Database
Chad Moretz, Yunping Zhou, Amol D Dhamane, et al.
Journal of Personalized Medicine
|
November 27, 2021
Unmanaged Pharmacogenomic and Drug Interaction Risk Associations with Hospital Length of Stay among Medicare Advantage Members with COVID-19: A Retrospective Cohort Study
Kristine Ashcraft, Chad Moretz, Chantelle Schenning, et al.
Circulation. Genomic and Precision Medicine
|
December 13, 2023
Real-World Genetic Testing Utilization Among Patients With Cardiomyopathy
Ana Morales, Chad Moretz, Sheng Ren, et al.
JAMA Network Open
|
October 24, 2022
Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With Colorectal Cancer
Chad Moretz, Stacey DaCosta Byfield, Kathryn E Hatchell, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Population Health Management
|
October 8, 2014
Racial/ethnic and gender differences in severity of diabetes-related complications, health care resource use, and costs in a Medicare population
Leslie Hazel-Fernandez, Yong Li, Damion Nero, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
October 22, 2021
Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations
Morgan Justice Fuoco, Richard A Mularski, Benjamin Wu, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
March 28, 2022
Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population
Sanjay Sethi, Barry J Make, Scott B Robinson, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
April 29, 2021
Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities
Ravi Kalhan, David Slade, Riju Ray, et al.
Epilepsia Open
|
December 10, 2023
Early genetic testing in pediatric epilepsy: Diagnostic and cost implications
Shanna M Swartwood, Ana Morales, Kathryn E Hatchell, et al.
Health and Quality of Life Outcomes
|
June 23, 2017
Healthcare utilization and costs for patients initiating Dabigatran or Warfarin
Shannon L Reynolds, Sameer R Ghate, Richard Sheer, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 19, 2015
Development and Validation of a Predictive Model to Identify Individuals Likely to Have Undiagnosed Chronic Obstructive Pulmonary Disease Using an Administrative Claims Database
Chad Moretz, Yunping Zhou, Amol D Dhamane, et al.
Journal of Personalized Medicine
|
November 27, 2021
Unmanaged Pharmacogenomic and Drug Interaction Risk Associations with Hospital Length of Stay among Medicare Advantage Members with COVID-19: A Retrospective Cohort Study
Kristine Ashcraft, Chad Moretz, Chantelle Schenning, et al.
Circulation. Genomic and Precision Medicine
|
December 13, 2023
Real-World Genetic Testing Utilization Among Patients With Cardiomyopathy
Ana Morales, Chad Moretz, Sheng Ren, et al.
JAMA Network Open
|
October 24, 2022
Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With Colorectal Cancer
Chad Moretz, Stacey DaCosta Byfield, Kathryn E Hatchell, et al.
Page
of 5